midry eye products

Review Product Information before prescribing, available on page 95 of this issue of mivision, from www.ebs.tga.gov.au, or Sun Pharma by calling (AUS) 1800 726 229.
This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at tga.gov.au/reporting-problems.
Date of preparation: July 2023 CEQ01/2023MIVI2

References
1. Cequa Approved Product Information. Pharmaceutical Benefits Scheme (pbs.gov.au).
2. Pharmaceutical Benefits Scheme (pbs.gov.au).

Viscotears Eye Gel provides soothing relief for sore, gritty dry eyes. Its long-lasting gel formulation is suited for those who need extra protection, added night-time support, or prefer a heavier gel. Viscotears Eye Gel maintains the tear film stability for a period of up to six hours. Viscotears Gel PF is an ophthalmic solution that has a moistening and wetting effect on the eyes. It improves the moistening of the ocular surface in the presence of dry eye sensation, burning or tiredness of the eyes.

The Oculus Keratograph 5M is an advanced placido-based corneal topographer with a built-in real keratometer and a colour camera optimised for external imaging. It has established itself as the most comprehensive dry eye analysis tool available with the Jenvis Pro dry eye report that supports objective grading for dry eye diagnosis. The software enables you to find the cause of dry eye in an easy and reliable way with screening, comprehensive DEWS II and follow-up protocols, leading to an optimised workflow that saves time. The software is also fully customisable and the easy-to-understand reports help to communicate the dry eye status to your patients.

Contact: CSL Seqirus Medical (AUS) 1800 642 865
Before prescribing, please review the Product Information available from cslseqirus.com.au/products or on page 103 of this issue of mivision.
This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at tga.gov.au/reporting-problems.

Date of Preparation: September 2023. AU-Iker-23-0059.
References available at mivision.com.au

Contact: Johnson and Johnson Account Manager
^31 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as primary or secondary endpoint for Acuvue Oasys brand two-weekly family and for Acuvue Oasys 1-Day brand family contact lenses as of 29 April 2022.
§ Improved optical performance and vision compared to Acuvue Oasys brand contact lenses with Hydraclear Plus Technology.
^^ Warning: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV- absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. Note: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV- blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders.
References available at mivision.com.au.

DryEye Forte is a patented, advanced oral supplement providing systemic dry eye relief and anti-inflammatory support. This comprehensive, evidence-based formula contains therapeutic levels of the Omega-3 fatty acids EPA and DHA from re-esterified, pharmaceutical grade fish oil that has been mercury-tested and sustainably sourced; GLA from plant-based borage oil; anti-inflammatory vitamin D3; vitamin E; and rich antioxidants including gamma-Tocopherol. Vitamin D deficiency has been clinically shown among dry eye sufferers. DryEye Forte ’s patented formula optimises the production of anti-inflammatory prostaglandins, reduces ocular inflammation, and restores a healthy tear film. Not sold in pharmacy.